Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis

Go back to Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis
Capital Gold (NASDAQ: CGC) Delayed: 0.96 -0.01 (1.03%)
Previous Close $0.97    52 Week High $6.57 
Open $0.96    52 Week Low $2.30 
Day High $1.00    P/E 3.43 
Day Low $0.95    EPS $0.28 
Volume 3,933,793       

(NYSE: WEED) Delayed: 20.19 -1.19 (5.57%)
Previous Close $21.38    52 Week High
Open $21.31    52 Week Low
Day High $21.44    P/E N/A 
Day Low $20.19    EPS
Volume 29,402